{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-5AEUL9JE/a17b7884-323c-4be5-b77d-518cdd5002e4/PDF","dcterms:extent":"167 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-5AEUL9JE/21a4f543-a4e3-4c2f-b6ab-ecd878028a07/TEXT","dcterms:extent":"33 KB"}],"edm:TimeSpan":{"@rdf:about":"1994-2025","edm:begin":{"@xml:lang":"en","#text":"1994"},"edm:end":{"@xml:lang":"en","#text":"2025"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-5AEUL9JE","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/URN:NBN:SI:spr-46R7GGHL"},{"@xml:lang":"sl","#text":"Medicinski razgledi"}],"dcterms:issued":"2011","dc:creator":["Ekart, Robert","Hojs, Nina","Svenšek, Franc"],"dc:format":[{"@xml:lang":"sl","#text":"številka:3"},{"@xml:lang":"sl","#text":"letnik:50"},{"@xml:lang":"sl","#text":"str. 347-356"}],"dc:identifier":["ISSN:0025-8121","COBISSID:4038719","URN:URN:NBN:SI:doc-5AEUL9JE"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Medicinski razgledi"},"dc:subject":[{"@xml:lang":"en","#text":"Acid-Base Equilibrium"},{"@xml:lang":"sl","#text":"Acido-bazno ravnotežje"},{"@xml:lang":"en","#text":"diagnosis"},{"@xml:lang":"en","#text":"Diagnostika"},{"@xml:lang":"en","#text":"Emergency Treatment"},{"@xml:lang":"en","#text":"Ethylene Glycol"},{"@xml:lang":"sl","#text":"Etilenglikol"},{"@xml:lang":"sl","#text":"klinična slika"},{"@xml:lang":"sl","#text":"Nujno ukrepanje"},{"@xml:lang":"en","#text":"Osmolar Concentration"},{"@xml:lang":"sl","#text":"Osmolarna koncentracija"},{"@xml:lang":"en","#text":"poisoning"},{"@xml:lang":"en","#text":"therapy"},{"@xml:lang":"sl","#text":"Zastrupitve"},{"@xml:lang":"sl","#text":"Zdravljenje"},{"@rdf:resource":"http://www.wikidata.org/entity/Q2861470"}],"dcterms:temporal":{"@rdf:resource":"1994-2025"},"dc:title":{"@xml:lang":"sl","#text":"Zastrupitev z etilenglikolom| Ethylene glycol intoxication|"},"dc:description":[{"@xml:lang":"sl","#text":"Ethylene glycol intoxications are quite rare. The toxicity of ethylene glycol is largerly related to its metabolites rather than the parent compound itself. Our case report represents the typical clinical findings (neurological, cardiopulmonary and renal phase) and laboratory results (elevated serum osmolality, high osmolar gap, high anion gap metabolic acidosis, calcium oxalate crystals in the urine) of an glycol intoxication. Given the potentially high morbidity and mortality of this intoxication, its quick recognition is essential. Treatment includes securing the patient's airway, breathing and circulation, administering bicarbonate and an antidote (ethanol, fomepizole), hemodialysis, and sometimes also the administration of cofactors of ethylene glycol metabolism (thiamine, pyridoxine, and magnesium)"},{"@xml:lang":"sl","#text":"Zastrupitve z etilenglikolom so dokaj redke. Etilenglikol je sam po sebi malo toksičen, hudo zastrupitev povzročajo predvsem njegovi presnovni produkti. Prikazani primer obravnava značilno klinično sliko (nevrološka, kardiopulmonalna in ledvična faza) in laboratorijske rezultate (povišana serumska osmolalnost, povišana osmolalna vrzel, metabolična acidoza s povišano anionsko vrzeljo, kristali kalcijevega oksalata v urinu) ob zastrupitvi z etilenglikolom. Hitra prepoznava je nujna, saj sta obolevnost in smrtnost po zastrupitvi visoki. Zdravljenje vključuje vzdrževanje dihalne poti, dihanja in krvnega obtoka, infuzijo bikarbonata, dajanje antidota (etanol, fomepizol), hemodializo, včasih tudi zdravljenje s kofaktorji presnove etilenglikola (tiamin, piridoksin, magnezij)"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-5AEUL9JE","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-5AEUL9JE"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-5AEUL9JE/a17b7884-323c-4be5-b77d-518cdd5002e4/PDF"},"edm:rights":{"@rdf:resource":"http://rightsstatements.org/vocab/InC/1.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Društvo Medicinski razgledi"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-5AEUL9JE/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-5AEUL9JE"}}}}